SELLAS Life Sciences (SLS) Total Non-Current Liabilities (2019 - 2022)
Historic Total Non-Current Liabilities for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2022 value amounting to $16.1 million.
- SELLAS Life Sciences' Total Non-Current Liabilities rose 18572.44% to $16.1 million in Q4 2022 from the same period last year, while for Dec 2022 it was $16.1 million, marking a year-over-year increase of 18572.44%. This contributed to the annual value of $16.1 million for FY2022, which is 18572.44% up from last year.
- SELLAS Life Sciences' Total Non-Current Liabilities amounted to $16.1 million in Q4 2022, which was up 18572.44% from $13.2 million recorded in Q3 2022.
- In the past 5 years, SELLAS Life Sciences' Total Non-Current Liabilities ranged from a high of $17.1 million in Q1 2022 and a low of $3.9 million during Q1 2020
- In the last 4 years, SELLAS Life Sciences' Total Non-Current Liabilities had a median value of $6.2 million in 2019 and averaged $8.5 million.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 5814.2% in 2021, then surged by 18572.44% in 2022.
- Over the past 4 years, SELLAS Life Sciences' Total Non-Current Liabilities (Quarter) stood at $5.6 million in 2019, then surged by 140.1% to $13.5 million in 2020, then plummeted by 58.14% to $5.6 million in 2021, then skyrocketed by 185.72% to $16.1 million in 2022.
- Its Total Non-Current Liabilities was $16.1 million in Q4 2022, compared to $13.2 million in Q3 2022 and $13.0 million in Q2 2022.